Type i and II endometrial cancers: Have they different risk factors?

Journal of Clinical Oncology

Volumn 31, Issue 20, 2013, Pages 2607-2618

  Setiawan, Veronica Wendy ^a   Yang, Hannah P ^e   Pike, Malcolm C ^a,f   McCann, Susan E ^w,y   Yu, Herbert ^j   Xiang, Yong Bing ^k   Wolk, Alicja ^l   Wentzensen, Nicolas ^e   Weiss, Noel S ^m   Webb, Penelope M ^o   Van Den Brandt, Piet A ^q   Van De Vijver, Koen ^q   Thompson, Pamela J ^j   Strom, Brian L ^a,r   Spurdle, Amanda B ^p   Soslow, Robert A ^f   Shu, Xiao Ou ^s   Schairer, Catherine ^e   Sacerdote, Carlotta ^t   Rohan, Thomas E ⁱ   Robien, Kim ^v   Risch, Harvey A ^w   Ricceri, Fulvio ^u   Rebbeck, Timothy R ^r   Rastogi, Radhai ^f   Prescott, Jennifer ^a   Polidoro, Silvia ^u   Park, YikYung ^e   Olson, Sara H ^f   Moysich, Kirsten B ^g   Miller, Anthony B ^z,ac   McCullough, Marjorie L ^ad   Matsuno, Rayna K ^j   Magliocco, Anthony M ^a   Lurie, Galina ^j   Lu, Lingeng ^v   Lissowska, Jolanta ^ae   Liang, Xiaolin ^f   Lacey, James V ^b   Kolonel, Laurence N ^j   Henderson, Brian E ^a   Hankinson, Susan E ^g   Hakansson, Niclas ^a   Goodman, Marc T ^j   Gaudet, Mia M ^ad   Garcia Closas, Montserrat ^af   Friedenreich, Christine M ^aa   Freudenheim, Jo L ^h   Doherty, Jennifer ^w,ag   De Vivo, Immaculata ^w,x   Courneya, Kerry S ^ab   Cook, Linda S ^ah   Chen, Chu ⁿ   Cerhan, James R ^ai   Cai, Hui ^t   Brinton, Louise A ^e   Bernstein, Leslie ^b   Anderson, Kristin E ^v   Anton Culver, Hoda ^c   Schouten, Leo J ^q   Horn Ross, Pamela L ^d   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^k SHANGHAI CANCER INSTITUTE   (China)

^l KAROLINSKA INSTITUTE   (Sweden)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

^o Australian National Endometrial Cancer Study Group   (Australia)

^p QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^q MAASTRICHT UNIVERSITY   (Netherlands)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^t Center for Cancer Prevention   (United States)

^u Human Genetics Foundation   (Italy)

^v UNIVERSITY OF MINNESOTA   (United States)

^w YALE UNIVERSITY   (United States)

^x HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^y UNIVERSITY OF MASSACHUSETTS   (United States)

^z UNIVERSITY OF TORONTO   (Canada)

^aa ALBERTA HEALTH SERVICES   (Canada)

^ab UNIVERSITY OF ALBERTA   (Canada)

^ac AMERICAN CANCER SOCIETY   (United States)

^ad H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^ae INSTITUTE OF ONCOLOGY   (Poland)

^af INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ag DARTMOUTH COLLEGE   (United States)

^ah UNIVERSITY OF NEW MEXICO   (United States)

^ai MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; BODY MASS; CANCER CLASSIFICATION; CANCER RISK; CONTRACEPTIVE BEHAVIOR; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MENARCHE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; ADENOCARCINOMA; ADULT; AGE; AGED; CANCER STAGING; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; ENDOMETRIUM TUMOR; FACTUAL DATABASE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEEDLE BIOPSY; OBESITY; PATHOLOGY; REVIEW; RISK; SENSITIVITY AND SPECIFICITY; SURVIVAL; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL; DATABASES, FACTUAL; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBESITY; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; SURVIVAL ANALYSIS;

EID: 84883854572     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.48.2596     Document Type: Article

References (29)

1. Sherman ME: Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod Pathol 13:295-308, 2000
2. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17, 1983
3. Hecht JL, Mutter GL: Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 24:4783-4791, 2006
4. Emons G, Fleckenstein G, Hinney B, et al: Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7:227-242, 2000
5. Moore KN, Fader AN: Uterine papillary serous carcinoma. Clin Obstet Gynecol 54:278-291, 2011
6. Prat J, Gallardo A, Cuatrecasas M, et al: Endometrial carcinoma: Pathology and genetics. Pathology 39:72-87, 2007
7. Felix AS, Weissfeld JL, Stone RA, et al: Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21:1851-1856, 2010
8. Bjørge T, Engeland A, Tretli S, et al: Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120:378-383, 2007
9. McCullough ML, Patel AV, Patel R, et al: Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 17:73-79, 2008
10. Sherman ME, Sturgeon S, Brinton LA, et al: Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 10:963-968, 1997
11. Uccella S, Mariani A, Wang AH, et al: Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: A prospective cohort study. Ann Oncol 22:2129-2136, 2011
12. Yang HP, Wentzensen N, Trabert B, et al: Endometrial cancer risk factors by 2 main histologic subtypes: The NIH-AARP Diet and Health Study. Am J Epidemiol 177:142-151, 2013
13. Olson SH, Chen C, De Vivo I, et al: Maximizing resources to study an uncommon cancer: E2C2-Epidemiology of Endometrial Cancer Consortium. Cancer Causes Control 20:491-496, 2009
14. Alvarez T, Miller E, Duska L, et al: Molecular profile of grade 3 endometrioid endometrial carcinoma: Is it a type I or type II endometrial carcinoma? Am J Surg Pathol 36:753-761, 2012
15. Voss MA, Ganesan R, Ludeman L, et al: Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer: A clinical and pathological evaluation. Gynecol Oncol 124:15-20, 2012
16. Key TJ, Pike MC: The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205-212, 1988
17. Yang HP, Brinton LA, Platz EA, et al: Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer 46:690-696, 2010
18. Al-Zoughool M, Dossus L, Kaaks R, et al: Risk of endometrial cancer in relationship to cigarette smoking: Results from the EPIC study. Int J Cancer 121:2741-2747, 2007
19. Zhou B, Yang L, Sun Q, et al: Cigarette smoking and the risk of endometrial cancer: A meta-Analysis. Am J Med 121:501-508.e3, 2008
20. Viswanathan AN, Feskanich D, De Vivo I, et al: Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study. Int J Cancer 114: 996-1001, 2005
21. Nestler JE, Powers LP, Matt DW, et al: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89, 1991
22. Friberg E, Orsini N, Mantzoros CS, et al: Diabetes mellitus and risk of endometrial cancer: A meta-Analysis. Diabetologia 50:1365-1374, 2007
23. Calle EE, Thun MJ: Obesity and cancer. Oncogene 23:6365-6378, 2004
24. Dossus L, Rinaldi S, Becker S, et al: Obesity, inflammatory markers, and endometrial cancer risk: A prospective case-control study. Endocr Relat Cancer 17:1007-1019, 2010
25. Kaaks R, Lukanova A, Kurzer MS: Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-1543, 2002
26. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al: Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 and risk of endometrial cancer. Int J Cancer 108:262-268, 2004
27. Cust AE, Kaaks R, Friedenreich C, et al: Plasma adiponectin levels and endometrial cancer risk in pre-And postmenopausal women. J Clin Endocrinol Metab 92:255-263, 2007
28. Zhou Y, Jorgensen EM, Gan Y, et al: Cigarette smoke increases progesterone receptor and homeobox A10 expression in human endometrium and endometrial cells: A potential role in the decreased prevalence of endometrial pathology in smokers. Biol Reprod 84:1242-1247, 2011
29. Soslow RA: Endometrial carcinomas with ambiguous features. Semin Diagn Pathol 27:261-273, 2010